PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34373857-0	2021	Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.	Mesalamine	0-10	angiotensin converting enzyme 2	Homo sapiens	30-34	
34373857-13	2021	Expression of ACE2 was reduced following mesalamine treatment in enteroids, while CTSL expression was increased.	Mesalamine	41-51	angiotensin converting enzyme 2	Homo sapiens	14-18	
34373857-18	2021	Mesalamine treatment reduced expression of the viral receptor ACE2 while concurrently increasing CTSL expression in human ileum organoids.	Mesalamine	0-10	angiotensin converting enzyme 2	Homo sapiens	62-66	
34849936-0	2022	Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.	Mesalamine	0-10	angiotensin converting enzyme 2	Homo sapiens	30-34